Resources Management Corp’s Regeneron Pharmaceuticals REGN Stock Holding History

Resources Management Corp’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-5	Closed	-$3K	–	517
2022 Q1	$3K	Hold	5	–	–	﹤0.01%	466
2021 Q4	$3K	Hold	5	–	–	﹤0.01%	476
2021 Q3	$3K	Hold	5	–	–	﹤0.01%	459
2021 Q2	$3K	Hold	5	–	–	﹤0.01%	470
2021 Q1	$2K	Hold	5	–	–	﹤0.01%	480
2020 Q4	$2K	Hold	5	–	–	﹤0.01%	471
2020 Q3	$3K	Hold	5	–	–	﹤0.01%	419
2020 Q2	$3K	Hold	5	–	–	﹤0.01%	445
2020 Q1	$2K	Sell	5 -10	-67%	-$4.13K	﹤0.01%	456
2019 Q4	$6K	Hold	15	–	–	﹤0.01%	412
2019 Q3	$4K	Buy	+15	New	+$4.44K	﹤0.01%	464

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Resources Management Corp's REGN Position: Q2 2022 in Review

Resources Management Corp sold out of Regeneron Pharmaceuticals (REGN) in Q2 2022, closing a stake of 5 shares — an estimated $3K sold.

Resources Management Corp first reported a position in REGN in Q3 2019 and held it in 11 quarters. The position peaked at $6K in Q4 2019. 1,064 funds tracked by Wall St. Rank hold REGN as of Q2 2022.

Resources Management Corp reported no remaining Regeneron Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
Resources Management Corp sold 5 Regeneron Pharmaceuticals shares in Q2 2022, an estimated $3K.
Resources Management Corp first reported a position in Regeneron Pharmaceuticals in Q3 2019 and held it in 11 quarters.
Resources Management Corp's Regeneron Pharmaceuticals position peaked at $6K in Q4 2019.
1,064 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2022.

Based on Resources Management Corp's 13F filing for Q2 2022, filed 10 Aug 2022.